Studies have shown that β-adrenoreceptors, especially ADRB1 and ADRB2, are highly expressed in pan cancers that significantly reduce the overall survival of tumor patients (Lehrer and Rheinstein, 2020). This evidence concerns the gene ADRB2 and neoplasm.